Adnan A. Jaigirdar - Concepedia

Author

Adnan A. Jaigirdar

University of California, San Francisco ORCID

Also Known As

A. Jaigirdar, Adnan A. Jaigirdar, Adnan Jaigirdar

Publications

379

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Center for Drug Evaluation and Research National Institutes of Health United States Food and Drug Administration

About

Adnan A. Jaigirdar is an author at University of California, San Francisco specializing in medicine, radiation oncology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	174
2	Health Sciences	2	2	103
3	Immunology	2	2	71
4	Blood Transplantation	1	1	15
5	Cell Biology	1	1	22

Adnan A. Jaigirdar

Publications

352

Citations

H-Index

Page 1

	Year	Citations
Acquisition of CD80 (B7-1) by T Cells Helen Sabzevari, Judy Kantor, Adnan A. Jaigirdar, The Journal of Immunology	2001	107
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer Sonia Singh, Adnan A. Jaigirdar, Flora Mulkey, Clinical Cancer Research Cancer ManagementPharmacotherapyMetronomic ChemotherapyPre-clinical PharmacologyOncology	2020	88
FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review Paz J. Vellanki, Flora Mulkey, Adnan A. Jaigirdar, Clinical Cancer Research	2021	54
Preferential Priming of Alloreactive T Cells with Indirect Reactivity Todd V. Brennan, Adnan A. Jaigirdar, Vunghi Hoang, American Journal of Transplantation Signal TransductionT-regulatory CellIndirect ReactivityImmunologyAutoimmunity	2009	49
A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells Adnan A. Jaigirdar, Steven A. Rosenberg, Maria R. Parkhurst Journal of Immunotherapy HistocompatibilityClass IiPeptide Wt1:126-134Hla ImmunogeneticsImmunology	2016	22
Coexisting Tattoo Pigment and Metastatic Melanoma in the Same Sentinel Lymph Node Adnan A. Jaigirdar, Michael W. Yeh, Emile Sharifi, Journal of Cutaneous Medicine and Surgery	2009	17
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma Mona Elmacken, Helkha Peredo-Pinto, Cong Wang, Clinical Cancer Research PharmacotherapyHematological MalignancyMetronomic TherapyHematologyClinical Trials	2024	15

Page 1